Your browser doesn't support javascript.
loading
[Secondary osteoporosis. Glucocorticoid excess-related osteoporosis.]
Yamauchi, Mika.
Afiliação
  • Yamauchi M; Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.
Clin Calcium ; 28(12): 1635-1640, 2018.
Article em Ja | MEDLINE | ID: mdl-30487328
Glucocorticoid(GC)excess is one of the most common causes of secondary osteoporosis, which can be associated with a disease(GC excess due to Cushing's syndrome)or with a treatment(GC medications). In addition to Cushing's syndrome, subclinical Cushing's syndrome, which occurs more frequently, can also increase the risk of fractures. Thus, it is important to consider these diseases when making the diagnosis for osteoporosis. GC-induced osteoporosis leads to reduction of bone mineral density and increased risk of fracture from the early stage after initiation of GC treatment, and thus requires management from the time of initiation. The 2014 revised Guidelines on the Management and Treatment of GC-induced Osteoporosis should be used routinely in the clinical settings as they introduce a scoring system that is easily adoptable.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Síndrome de Cushing / Fraturas Ósseas Tipo de estudo: Etiology_studies / Guideline Limite: Humans Idioma: Ja Revista: Clin Calcium Assunto da revista: METABOLISMO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Síndrome de Cushing / Fraturas Ósseas Tipo de estudo: Etiology_studies / Guideline Limite: Humans Idioma: Ja Revista: Clin Calcium Assunto da revista: METABOLISMO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão